Prognostic Value of Genomic Analysis After Neoadjuvant Chemotherapy for Breast Cancer
Mayer EL et al. Prognostic value of genomic analysis after neoadjuvant chemotherapy for breast cancer. San Antonio Breast Cancer Symposium 2010;Abstract P3-10-13.
Dr Burstein is Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts.
|